Episode 35: Can Azithromycin Help Poorly Controlled Childhood Asthma?

Originally Recorded 4/18/2023   Welcome to Season Two of Allergytalk! In this season, we are going to introduce you to each of the Allergy Watch assistant editors who work so hard on scouring the literature in allergy and immunology and bring you the most interesting articles in every issue! For this episode we welcome Dr. Shyam Joshi, MD from Oregon Health and Science University and will be reviewing three articles from the Nov-Dec 2022 issue of Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology. Articles Reviewed: In Kids With Allergic Rhinitis, Remember To Address Sleep Problems!   Allergic disease, sleep problems, and psychological distress in children recruited from the general community.   Azithromycin as an Option for Poorly Controlled Childhood Asthma    Azithromycin for Poorly Controlled Asthma in Children: A Randomized Controlled Trial.   Data Suggest ‘Real-World Benefit’ of Early Introduction   Changes in Australian food anaphylaxis admission rates following introduction of updated allergy prevention guidelines.   Please rate our podcast on iTunes! Please give us feedback, corrections, and suggestions! Email feedback to: [email protected]   ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced. Today’s speakers have the following disclosures: Dr. Lee has nothing to disclose Dr. Joshi has the following disclosures: Advisory board: Takeda Leo Pharma Sanofi/Regeneron Nectar Allergy Cogent Clinical trial funding: GlaxoSmithKline Sanofi Dr. Fineman Speaker: Takeda; Research: Aimmune, DBV, Biocryst